JW Shinyak Corporation (KOSDAQ:067290)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,260.00
0.00 (0.00%)
At close: Feb 19, 2026
Market Cap138.56B +71.0%
Revenue (ttm)76.02B -25.0%
Net Income10.16B +38.2%
EPS175.31 +28.8%
Shares Out55.87M
PE Ratio14.15
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,602,544
Average Volume2,689,052
Open2,190.00
Previous Closen/a
Day's Range2,160.00 - 2,395.00
52-Week Range1,220.00 - 2,605.00
Beta0.71
RSI71.65
Earnings DateMar 18, 2026

About JW Shinyak

JW Shinyak Corporation engages in the research, development, production, and sale of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rheum... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1981
Employees 183
Stock Exchange KOSDAQ
Ticker Symbol 067290
Full Company Profile

Financial Performance

Financial Statements